Metsera Becomes The Prize In Obesity's Biggest Bidding War

Metsera, Inc. is at the center of a bidding war between Novo Nordisk and Pfizer, driving its stock up 20%. Learn more about ...
Hosted on MSN

Wegovy vs. Ozempic: Which Is the Better Weight Loss Drug?

Ozempic and Wegovy are both glucagon-like peptide-1 (GLP-1) receptor agonists and contain the active ingredient semaglutide. They share many similarities, and both effectively lower cardiovascular ...
Nasdaq

Is Novo Nordisk Increasing Dosage to Defend Wegovy's Edge in Obesity?

Novo Nordisk NVO announced that it has submitted a regulatory application to the European Medicines Agency (EMA) seeking approval for a new and higher dose of its popular obesity medication, Wegovy ...

I’m fed up of miserable side effect after switching to Wegovy – but I’ll hit 7st weight loss thanks to huge benefit

KENNIDEE Cox started her weight loss jab journey just over a year ago and has already seen her figure transformed. But the ...

Metsera the US obesity biotech at centre of Novo, Pfizer bidding war

Founded in 2022 by Population Health Partners and ARCH Venture Partners, the biotech venture giant led by Bob Nelsen, Metsera ...